Back to
WELLINGTON MANAGEMENT GROUP LLP
RAREShowing 8 of 14 quarters
Position history for
WELLINGTON MANAGEMENT GROUP LLP's holdings in ULTRAGENYX PHARMACEUTICAL IN
WELLINGTON MANAGEMENT GROUP LLP holds 2.6M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $55.3M as of 2026-Q1. The position was increased (+7.3% shares). RARE represents 0.0% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.
Current Value
$55.3M
Current Shares
2.6M
Total Value Change
-$131.9M
Total Shares Change
-1.9M
Quarter-by-Quarter History
Other major holders of RARE: Capital Research Global Investors, Capital International Investors, FEDERATED HERMES, INC.